Pay in 4 interest-free payments of $5.05 Learn more
Ships within 48 hours · Estimated delivery Sep 22 - Sep 27
Efficacy and safety of telaglenastat plus cabozantinib vs placebo plus cabozantinib in patients with advanced renal cell carcinoma: the CANTATA randomized clinical trial
Presented for research literature review only Young PR et al
M.Maurovich-HorvatP.LiuC
Key Differences Summary# Molecular design : Amycretin is a single molecule activating two receptors
Pharmacological treatment modalities such as glucagon-like peptide-1 (GLP-1) receptor agonists and dipeptidyl peptidase-4 (DPP-4) inhibitors have become increasingly accepted as viable antidiabetic treatment options due to their safety and favorable cardiovascular profiles [9, 10]
US$ 27.35
US$ 24.58
US$ 29.78
US$ 25.76
US$ 28.14
US$ 28.09
US$ 21.18
US$ 22.58
US$ 25.35
